➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Last Updated: August 4, 2020

DrugPatentWatch Database Preview

KENALOG-10 Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Kenalog-10 patents expire, and what generic alternatives are available?

Kenalog-10 is a drug marketed by Apothecon and is included in one NDA.

The generic ingredient in KENALOG-10 is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Seventy suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.

Drug patent expirations by year for KENALOG-10
Drug Prices for KENALOG-10

See drug prices for KENALOG-10

Recent Clinical Trials for KENALOG-10

Identify potential brand extensions & 505(b)(2) entrants

University of South FloridaPhase 3
University of WashingtonEarly Phase 1
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Early Phase 1

See all KENALOG-10 clinical trials

Pharmacology for KENALOG-10

US Patents and Regulatory Information for KENALOG-10

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apothecon KENALOG-10 triamcinolone acetonide INJECTABLE;INJECTION 012041-001 Approved Prior to Jan 1, 1982 RX Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.